炎症性肠病患者的外周血嗜酸性粒细胞增多定义了一种侵袭性疾病表型
该研究基于2009至2014年一家三级中心的前瞻性自然病史炎症性肠病(IBD)队列登记数据,分析2,066例IBD患者中外周血嗜酸性粒细胞增多(PBE)的多年模式及其对疾病严重程度的影响。结果显示19.2%的患者出现PBE,PBE与溃疡性结肠炎(UC)、广泛性结肠炎及较短病程显著相关,并与更活跃的疾病、更高的医疗资源利用和更短至住院或手术时间相关。作者认为PBE代表一种具有独特炎症特征且临床结局更差的IBD亚组生物标志物。
要点
- 在2,066例IBD患者中,19.2%出现外周血嗜酸性粒细胞增多(PBE)。
- PBE与UC(P<0.001)、广泛性结肠炎(P<0.001)及较短病程(P=0.03)显著相关。
- PBE患者住院、IBD手术及使用泼尼松、抗TNF治疗的比例均显著更高(均P<0.001)。
核心结论
- 这项多年期大型IBD队列研究提示,外周血嗜酸性粒细胞增多代表一个具有独特炎症特征且临床结局更差的IBD亚组生物标志物。
研究设计与样本
- 研究为2009至2014年一家三级中心经知情同意的前瞻性自然病史IBD队列的登记分析,共纳入2,066例IBD患者,比较有PBE与无PBE患者在人口学、合并症、疾病活动度、医疗资源利用及至住院或手术切除时间方面的差异。
主要发现
- 2,066例IBD患者中19.2%出现PBE,PBE与UC(P<0.001)、广泛性结肠炎(P<0.001)及较短病程(P=0.03)显著相关。
- 六年随访期间,PBE患者疾病更活跃(Harvey-Bradshaw指数P=0.001;溃疡性结肠炎活动指数P<0.001),合并C反应蛋白升高(P<0.001),医疗资源利用更多(住院P<0.001,IBD手术P<0.001),药物治疗更积极(泼尼松P<0.001,抗TNF P<0.001)。
- PBE患者至住院时间在UC(P<0.001)和克罗恩病(CD)(P<0.001)中均显著缩短,UC中至结肠切除术时间亦缩短(P=0.003)。
- 多变量模型显示,PBE在CD和UC中均仍与住院和手术显著相关。
- 新诊断UC伴PBE与泼尼松(P=0.007)和抗TNF(P=0.001)需求增加相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Peripheral blood eosinophilia (PBE) in inflammatory bowel disease (IBD) is associated with ulcerative colitis (UC) and active disease. Little data exist on the long-term impact of PBE on disease course. We aimed to investigate the multi-year patterns of PBE and its impact on disease severity in a large IBD cohort. METHODS: We performed a registry analysis of a consented, prospective, natural history IBD cohort at a tertiary center from 2009 to 2014. Demographics, comorbidities, disease activity, healthcare utilization, and time to hospitalization or surgical resection of patients who displayed PBE were compared to patients without PBE. RESULTS: Of the 2,066 IBD patients, 19.2% developed PBE. PBE was significantly associated with UC (P<0.001), extensive colitis (P<0.001), and shorter disease duration (P=0.03). Over six years, PBE patients had more active disease (Harvey-Bradshaw Index P=0.001; ulcerative colitis activity index P<0.001), concurrent C-reactive protein elevation (P<0.001), healthcare utilization (hospitalization P<0.001, IBD surgery P<0.001), and more aggressive medical therapy (prednisone P<0.001, anti-TNF P<0.001). Patients with PBE had a significantly reduced time to hospitalization in both UC (P<0.001) and Crohn's disease (CD) (P<0.001) and reduced time to colectomy in UC (P=0.003). On multivariable modeling, PBE remained significantly associated with hospitalization and surgery in both CD and UC. New diagnosis of UC with PBE was associated with increased steroid (P=0.007) and anti-TNF (P=0.001) requirement. CONCLUSION: This multi-year study of a large IBD cohort suggests that peripheral blood eosinophilia represents a biomarker of a distinct IBD subgroup, with a unique inflammatory signature, and at risk for worse clinical outcomes.
引用
- Click B, Anderson AM, Koutroubakis IE, et al. Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype. Am J Gastroenterol. 2017. PMID: 29112200. doi:10.1038/ajg.2017.402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。